Atlas Trials

CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet

Clinical trial NCT01329562 · COMPLETED

Trial details

NCT number
NCT01329562
Sponsor
Cady, Roger, M.D.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Menstrual Migraine
Start date
2011-05-01
Primary completion
2012-06-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.